Hamilton Thorne Announces Delay in G2 2017 Financial Results Release and Conference Call
August 22 2017 - 9:25AM
Hamilton Thorne Ltd. (TSX-V:HTL) today announced a delay in the
release of its financial results for the three and six months ended
June 30, 2017 and related conference call in order to allow
additional time to conclude the accounting for the period. The
Company will announce the timing of the rescheduled conference in a
press release concurrent with the release of financial results,
which will be delivered within the requisite period. The press
release, with accompanying financial information, will be posted on
the Company’s website at www.hamiltonthorne.com and on
www.sedar.com.
About Hamilton Thorne Ltd.
(www.hamiltonthorne.com)
Hamilton Thorne is a leading global provider of precision
instruments, consumables, software and services that reduce cost,
increase productivity, improve results and enable breakthroughs in
Assisted Reproductive Technologies (ART) and developmental biology
research markets. Hamilton Thorne markets its products and services
under the Hamilton Thorne, Gynemed and Embryotech Laboratories
brands, through its growing sales force and distributors worldwide.
Hamilton Thorne’s customer base consists of fertility clinics,
university research centers, animal breeding facilities,
pharmaceutical companies, biotechnology companies, and other
commercial and academic research establishments.
Neither the Toronto Venture Exchange, nor its regulation
services provider (as that term is defined in the policies of the
exchange), accepts responsibility for the adequacy or accuracy of
this release.
For more information, please contact:
David Wolf, President & CEO
Hamilton Thorne Ltd.
978-921-2050
ir@hamiltonthorne.com
Michael Bruns, CFO
Hamilton Thorne Ltd.
978-921-2050
ir@hamiltonthorne.com
Hamilton Thorne (TSXV:HTL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Hamilton Thorne (TSXV:HTL)
Historical Stock Chart
From Apr 2023 to Apr 2024